University of Iowa Health Care picks Zingbox to monitor its IoT medical devices
Through its IoT Guardian solution, Zingbox provides real-time risk assessment across the health system's network of more than 45,000 connected medical devices.
IDx raises $33M Series A after its AI-powered screening tool received an FDA nod
The company's technology for screening diabetic retinopathy was granted "Breakthrough Device" designation and is able to provide a clinical decision, instead of simply a recommendation to the physician.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
FDA greenlights tool for automated detection of diabetic retinopathy in primary care
The marketing clearance follows the FDA's decision to approve a "breakthrough device" designation for IDx-DR, accelerating the review process for the product based on its ability to address an unmet medical need.